InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.62
(
-0.34%
)
Bitcoin
58,813.07
(
-2.24%
)
Post# of 252478
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: mcbio post# 165956

Wednesday, 09/04/2013 10:01:21 AM

Wednesday, September 04, 2013 10:01:21 AM

Post# of 252478
ARQL:

But, I have to lower my outlook on chances of success for P3 HCC trial now.



That's putting it pretty kindly isn't it?

If I'm not mistaken, there are zero prior data for efficacy at the 120 dose for HCC upon which we can extrapolate for the phase 3. I'm surprised that people are actually discussing this situation rather than running away screaming.

I don't think it's in the newbie rules but there's gotta be one added that says something like "Never bet on a phase 3 that is using a drug at a dose for which there are no prior data."
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up